Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Ototoxicity × Cisplatin × Clear all

Phase

Status

Withdrawn 1 Suspended 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 201 Head and Neck Neoplasms 131 Squamous Cell Carcinoma of Head and Neck 112 Stomach Neoplasms 105 Lung Neoplasms 101 Esophageal Neoplasms 85 Uterine Cervical Neoplasms 63 Neoplasms 59 Urinary Bladder Neoplasms 49 Breast Neoplasms 45 Pancreatic Neoplasms 43 Esophageal Squamous Cell Carcinoma 41 Small Cell Lung Carcinoma 40 Ovarian Neoplasms 40 Adenocarcinoma Of Esophagus 36 Neoplasm Metastasis 34 Carcinoma, Squamous Cell 32 Carcinoma, Ovarian Epithelial 30 Mesothelioma, Malignant 27 Lymphoma 26 Parkinson Disease 4, Autosomal Dominant Lewy Body 23 Adenocarcinoma of Lung 22 Gallbladder Neoplasms 20 Cholangiocarcinoma 20 Unspecified Adult Solid Tumor, Protocol Specific 19 Sarcoma 19 Nasopharyngeal Carcinoma 19 Melanoma 19 Biliary Tract Neoplasms 19 Adenocarcinoma 18

Interventions

sodium thiosulfate 2 Thioctic Acid 1 Surveys and Questionnaires 1 Sodium Chloride 1 Pantoprazole 1 Methotrexate 1 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 Hyaluronic Acid 1 Hearing Tests 1 Genetic Association Studies 1 Cisplatin 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00652132 2018-05-29

SIOPEL6

University of Birmingham

Phase 3 Completed

116 enrolled 1 FDA

Gastrointestinal

Ototoxicity, Liver Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡